Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
NCT05536271Phase 2Completed
- Sponsor
- Damanhour University
- Start
- Sep 2021
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bisoprolol in acute coronary syndrome (ACS), sponsored by Damanhour University. Started Sep 2021; status: completed.
02
Drugs
bisoprolol
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT05536271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05536271.